September/October 2017 - Volume 40 - Issue 5
pp: 195-237

A Randomized Double-Blind Placebo-Controlled Phase III Trial of Selegiline Monotherapy for Early Parkinson Disease

Mizuno, Yoshikuni; Hattori, Nobutaka; Kondo, Tomoyoshi; More

Clinical Neuropharmacology. 40(5):201-207, September/October 2017.